These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3315615)

  • 1. Non-exchange of streptokinase from anisoylated plasminogen streptokinase activator complex and other acylated streptokinase-plasminogen complexes.
    Smith RA
    Drugs; 1987; 33 Suppl 3():75-9. PubMed ID: 3315615
    [No Abstract]   [Full Text] [Related]  

  • 2. Deacylation studies in vitro on anisoylated plasminogen streptokinase activator complex.
    Ferres H; Hibbs M; Smith RA
    Drugs; 1987; 33 Suppl 3():80-2. PubMed ID: 3315616
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrin binding. An essential property of anisoylated plasminogen streptokinase activator complex.
    Banton CJ; Overell BG
    Drugs; 1987; 33 Suppl 3():93-6. PubMed ID: 2824169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy.
    Crabbe SJ; Grimm AM; Hopkins LE
    Pharmacotherapy; 1990; 10(2):115-26. PubMed ID: 2140889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of anistreplase.
    Sherry S
    Clin Cardiol; 1990 Mar; Suppl 5():V3-10; discussion V27-32. PubMed ID: 2182238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective effect of acylation on the stability of anisoylated plasminogen streptokinase activator complex in human plasma.
    Fears R; Ferres H; Standring R
    Drugs; 1987; 33 Suppl 3():57-63. PubMed ID: 2960514
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of anisoylated plasminogen-streptokinase activator complex from the acyl enzyme concept.
    Fears R
    Semin Thromb Hemost; 1989 Apr; 15(2):129-39. PubMed ID: 2665083
    [No Abstract]   [Full Text] [Related]  

  • 8. Haematological effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study.
    Monassier JP; Hanssen M
    Drugs; 1987; 33 Suppl 3():247-52. PubMed ID: 2445540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of heparin and fibrin on the enzymatic efficiencies of thrombolytics in vitro.
    Fears R
    Drugs; 1987; 33 Suppl 3():69-74. PubMed ID: 2960515
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fibrinolysis in vitro by acylated derivatives of a plasmin-streptokinase activator complex].
    Aĭsina RB; Popova GIu; Eremeev NL; Kazanskaia NF
    Ukr Biokhim Zh (1978); 1991; 63(2):27-31. PubMed ID: 1882459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symposium on anisoylated plasminogen streptokinase activator complex (APSAC). Proceedings of an international symposium. Guernsey, 5-6 November 1986.
    Drugs; 1987; 33 Suppl 3():1-316. PubMed ID: 3315573
    [No Abstract]   [Full Text] [Related]  

  • 12. Acylated derivatives of streptokinase-plasminogen activator complex as thrombolytic agents in a dog model of aged venous thrombosis.
    Dupe RJ; Green J; Smith RA
    Thromb Haemost; 1985 Feb; 53(1):56-9. PubMed ID: 3887635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Binding of an acylated plasminogen activator-streptokinase complex with fibrin and the fibrinolytic response in vitro].
    Aĭsina RB; Zhitkova IuV; Varfolomeev SD
    Vopr Med Khim; 1994; 40(3):31-5. PubMed ID: 8079435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a sustained fibrinolytic response to anisoylated plasminogen streptokinase activator complex in vitro.
    Fears R
    Drugs; 1987; 33 Suppl 3():83-7. PubMed ID: 3315617
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for the progressive uptake of anisoylated plasminogen streptokinase activator complex by clots in human plasma in vitro.
    Fears R; Ferres H; Standring R
    Drugs; 1987; 33 Suppl 3():51-6. PubMed ID: 2960513
    [No Abstract]   [Full Text] [Related]  

  • 16. Acyl enzymes for thrombolytic therapy.
    Walker ID; Davidson JF
    Semin Thromb Hemost; 1987 Apr; 13(2):139-45. PubMed ID: 3306926
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of acylated streptokinase-plasminogen complex and streptokinase in healthy volunteers.
    Prowse CV; Hornsey V; Ruckley CV; Boulton FE
    Thromb Haemost; 1982 Apr; 47(2):132-5. PubMed ID: 7048621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and side effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study.
    Monassier JP; Hanssen M
    Drugs; 1987; 33 Suppl 3():282-5. PubMed ID: 3315608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous bolus application of streptokinase and of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Clinical and haemostaseological findings.
    Hellstern P; Doenecke P; Köhler M; Schwerdt H; Ozbek C; Miyashita C; Bette L; Wenzel E
    Drugs; 1987; 33 Suppl 3():183-5. PubMed ID: 3315589
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetic properties of anisoylated plasminogen streptokinase activator complex and other thrombolytic agents in animals and in humans.
    Nunn B; Esmail A; Fears R; Ferres H; Standring R
    Drugs; 1987; 33 Suppl 3():88-92. PubMed ID: 3315618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.